Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
Bone Metastases
Brain Cancer
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Genitourinary Cancers
Head & Neck Cancers
Hematologic Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Non-Hodgkin Lymphoma
Oncology Nursing News
Patient Resources
Sarcomas/TGCT
Special Reports in Personalized Cancer Care
Supportive Care
Online CME
Interactive Publications
SELECT A TOPIC
CURRENT VIEW
All Specialties
▲
Education ▲
Education ▼
Register
|
Login
Conference Coverage
Videos
NewsNetwork
OncLive
®
TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
More >>
OncLive TV: Axel Hoos, MD, PhD
<< Back to Our Featured Experts
Dr. Hoos Discusses the Next Steps for Ipilimumab
Dr. Hoos Discusses Patients Eligible to Receive Ipilimumab
Dr. Hoos on the Ipilimumab Plus Dacarbazine Trial
Dr. Hoos on Why Melanoma is Amenable to Immunotherapy
Dr. Hoos Explains the Future of Immunotherapy
Dr. Hoos Describes Ipilimumab and Future Immunotherapies
Dr. Hoos on Tools Available to Measure Ipilimumab's Success
Dr. Hoos Discusses the Clinical Kinetics of Immunotherapy
Dr. Hoos on a Possible Successor Drug to Ipilimumab
Dr. Hoos Discusses Key Points of the Ipilimumab Trial
Oncology Specialists
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Siavash Jabbari, MD
Elias Jabbour, MD
David M. Jackman, MD
David M. Jackman
Graham Jackson, MD, PhD
Ryan W. Jacobs, MD
Paul B. Jacobsen, PhD
Dana Jacoby
Sundar Jagannath, MD
Beata Jagielska, MD, PhD
Thierry M. Jahan, MD
Mohammad Jahanzeb, MD
Manoj K. Jain, MD
Nitin Jain, MD
Shikha Jain, MD
Andrzej Jakubowiak, MD, PhD
Danelle James, MD, MAS
Mike Janicek, MD
Yelena Y. Janjigian, MD
Filip Janku, MD, PhD
Wolfgang Janni, MD, PhD
William R. Jarnagin, MD
William R. Jarnagin, MD, FACS
Andrew Jennis, MD
James R. Jett, MD
Komal Jhaveri, MD
Komal L. Jhaveri, MD
Komal Jhaveri, MD, FACP
Komal L. Jhaveri, MD, FACP
Yixing Jiang, BM, PhD
Heather S. Jim, PhD
Maxine S. Jochelson, MD
Heikki Joensuu, MD, PhD
Douglas B. Johnson, MD
Melissa Johnson, MD
Melissa L. Johnson, MD
Peter A. Johnstone, MD
Eric Jonasch, MD
Jeffrey Jones, MD
Jeffrey Jones, MD, MPH
Ben Jones
Terrill Jordan
Richard Joseph, MD
Richard W. Joseph, MD
Robert M. Jotte, MD, PhD
Claud M. Grigg Jr, MD
Gilberto Lopes Jr, MD
Paul A. Bunn Jr, MD
Primo N. Lara Jr, MD
Mario M. Leitao Jr, MD, FACOG, FACS
Tomi Jun, MD
Joseph Jurcic, MD
Evolving HCC Treatment Paradigm: Combinations and Sequencing
Trending Now
FDA Grants Abatacept Breakthrough Designation for Acute GVHD
Addressing Belantamab Mafodotin-Related Corneal Events in Myeloma is Key to Continuing Treatment
Patient Factors Critical to Treatment Selection in Prostate Cancer, RCC
Prostate Cancer Treatment Options Expand With ADT Combinations
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
x
Subscribe